Comments
Loading...

Kymera Therapeutics

KYMRNASDAQ
Logo brought to you by Benzinga Data
$43.70
3.097.61%
At close: -
$43.70
0.000.00%
After Hours: 4:00 PM EDT

Kymera Therapeutics (NASDAQ:KYMR) Stock Quotes, Forecast and News Summary

Kymera Therapeutics Stock (NASDAQ: KYMR) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
2
Aug 24
2
Sep 24
4
1
Nov 24
3
1
Dec 24
1
Jan
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.4
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$41.65
Close$43.70
Volume / Avg.454.30K / 464.41K
Day Range$41.00 - $44.03
52 Wk Range26.34 - 53.27
Market Cap$2.83B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
55
Short Interest
15.12%
Days to Cover17.52

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
KYMR
TWST

FAQ

Q

How do I buy Kymera Therapeutics (KYMR) stock?

A

You can purchase shares of Kymera Therapeutics (NASDAQ:KYMR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Kymera Therapeutics (KYMR) competitors?

Q

What is the forecast, or price target, for Kymera Therapeutics (KYMR) stock?

A

Kymera Therapeutics has a consensus price target of $50.42.

Q

What is the current price for Kymera Therapeutics (KYMR)?

A

The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $43.7 last updated January 21, 2025 at 4:00 PM EST.

Q

Does Kymera Therapeutics (KYMR) pay a dividend?

A

There are no upcoming dividends for Kymera Therapeutics.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics’s Q4 earnings are confirmed for Thursday, February 20, 2025.

Q

Is Kymera Therapeutics (KYMR) going to split?

A

There is no upcoming split for Kymera Therapeutics.

Q

What sector and industry does Kymera Therapeutics (KYMR) operate in?

A

Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch